Review for 'A 52‐week randomized controlled trial of ipragliflozin or sitagliptin in type 2 diabetes combined with metformin: The N‐ISM study'

MLA

Yoshio Nagai. Review for “A 52‐week Randomized Controlled Trial of Ipragliflozin or Sitagliptin in Type 2 Diabetes Combined with Metformin: The N‐ISM Study.” Sept. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........0ab1bbfa09e17519c47992ce065bf6d2&authtype=sso&custid=ns315887.

APA

Yoshio Nagai. (2020). Review for “A 52‐week randomized controlled trial of ipragliflozin or sitagliptin in type 2 diabetes combined with metformin: The N‐ISM study.”

Chicago

Yoshio Nagai. 2020. “Review for ‘A 52‐week Randomized Controlled Trial of Ipragliflozin or Sitagliptin in Type 2 Diabetes Combined with Metformin: The N‐ISM Study,’” September. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........0ab1bbfa09e17519c47992ce065bf6d2&authtype=sso&custid=ns315887.